Adrijana brings more than 20 years of experience across medicinal chemistry, commercial development and executive leadership, most recently as Global Head of Drug Discovery at Selvita having overseen its acquisition of Fidelta where she was previously CEO and COO. She holds a PhD in Organic Chemistry from the University of Zagreb and an MBA from Cotrugli Business School, Croatia.
